The inclusion of the Metropolitan Museum of Art and the Cloisters complements the existing museum options available to Scotch ...

Pinterest's AI advancements, shoppable ads, and strong Q4 results drive positive analyst outlook, boosting shares.

The OceanSound Partners-backed contractor makes this divestiture following a trio of acquisitions that concentrated on ...

Analysts at StockNews.com began coverage on shares of Aptiv (NYSE:APTV – Get Free Report) in a note issued to investors on ...

Rockline Wealth Management LLC boosted its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 5.5% in the fourth ...

NORTH CHICAGO, Ill. - The U.S. Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and avibactam) for the ...

Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company with a market capitalization of $569 million, has dosed the first patient in its Phase 2 HORIZON Study of MZE829, ...

Trade war fears may lead to significant market losses. Find out why Simplify’s CTA ETF is a better hedging option than KMLM, ...

Read about DMI's divestiture of its digital engineering services segment to Encora to increase its focus on digital transformation and managed services for public sector customers.

Please be advised that today's conference is being recorded. I would now like to hand the conference over to Sally Schwartz, Vice President of Investor Relations. Hello everyone and welcome to our ...

TD Cowen analyst Ritu Baral maintained a Buy rating on ACADIA Pharmaceuticals (ACAD – Research Report) today and set a price target of $35.00.